☆ 4.7 Article

A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents

ANTIVIRAL RESEARCH (2021)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Spike mutation D614G alters SARS-CoV-2 fitness

Jessica A. Plante et al.

Summary: The D614G substitution in the SARS-CoV-2 spike protein enhances viral replication and infectivity in human lung epithelial cells, primary airway tissues, and hamsters. This variant may increase transmission in the upper respiratory tract and doesn't seem to significantly reduce vaccine efficacy. Further research on therapeutic antibodies targeting the circulating G614 virus is recommended.

NATURE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging

Wioletta Rut et al.

Summary: A team of researchers synthesized a new type of antiviral agent, demonstrating through experiments its high efficacy in inhibiting SARS-CoV-2 with a low effective concentration, providing new insights for antiviral treatment. By observing the active SARS-CoV-2 M-pro in the cells of patients infected with COVID-19, important clues were provided for the design of antiviral drugs and diagnostic tests.

NATURE CHEMICAL BIOLOGY (2021)

Add to Collection

Article Microbiology

AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19

Steven S. Good et al.

Summary: AT-527, an oral antiviral drug, has potent activity against various coronaviruses, including SARS-CoV-2. In vitro experiments have shown that AT-511 has high efficacy in inhibiting the replication of SARS-CoV-2, with minimal cytotoxicity. Studies suggest that AT-527 may be an effective treatment option for COVID-19.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Add to Collection

Review Microbiology

SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development

Nicholas Murgolo et al.

Summary: This article discusses the key molecular and cellular interactions involved in SARS-CoV-2 infection to support current and future drug discovery efforts. While there are currently no FDA-approved treatments for COVID-19, potential antiviral compounds have been identified through drug repurposing screens.

PLOS PATHOGENS (2021)

Add to Collection

Article Immunology

The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract

Yuejun Shi et al.

Summary: The study found that in a mouse model infected with SARS-CoV-2, GS441524 effectively blocked the replication of the virus through intranasal and intramuscular treatment, whereas the efficacy of GC376 was weaker. A low-dose combination of GS441524 and GC376 could effectively protect mice from infection and showed a synergistic effect when used together.

EMERGING MICROBES & INFECTIONS (2021)

Add to Collection

Article Chemistry, Medicinal

Prodrugs of a 1′-CN-4-Aza-7,9-dideazaadenosine C-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV

Richard L. Mackman et al.

Summary: A discovery program identified C-nucleoside 4 as a potential lead compound for respiratory syncytial virus (RSV), which led to the discovery of the more potent drug remdesivir. In vitro metabolism studies confirmed the rapid formation of the active metabolite 1-NTP, and in vivo studies in monkeys showed significant reduction in lung viral load following administration of remdesivir. These early data supported the potential of remdesivir as a novel treatment for RSV prior to its development for other diseases.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 variants reveal features critical for replication in primary human cells

Marie O. Pohl et al.

Summary: This study characterized different SARS-CoV-2 isolates from major European clades during the early phase of the pandemic in 2020 and identified sequence features associated with distinct phenotypes, such as variations affecting replication in specific cell types. It highlights the importance of carefully monitoring newly emerging variants or potential variants of concern in SARS-CoV-2 stocks.

PLOS BIOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium

Philip V'kovski et al.

Summary: The study found that SARS-CoV-2 replicates more efficiently at a lower temperature (33 degrees Celsius) compared to normal body temperature (37 degrees Celsius). Both viruses were sensitive to interferon, but temperature affected the type and magnitude of interferon and pro-inflammatory responses induced by SARS-CoV and SARS-CoV-2.

PLOS BIOLOGY (2021)

Add to Collection

Article Microbiology

The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways

Manon Laporte et al.

Summary: The high transmissibility of SARS-CoV-2 is related to the virus's abundant replication in the upper airways, which differs from other highly pathogenic coronaviruses. The spike protein of SARS-CoV-2 exhibits intrinsic temperature preference, optimizing the virus for the human respiratory tract and enhancing its transmission. Additionally, certain proteases in the human airways play a key role in activating the spike protein for virus entry, further increasing SARS-CoV-2's ability to spread.

PLOS PATHOGENS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

A Phylodynamic Workflow to Rapidly Gain Insights into the Dispersal History and Dynamics of SARS-CoV-2 Lineages

Simon Dellicour et al.

Summary: Researchers have developed a rapid analytical pipeline to study the spatiotemporal dispersal history and dynamics of SARS-CoV-2 lineages, focusing on the high density of available genetic data in Belgium. This methodology can be quickly applied to other countries or regions to complement epidemiological analyses and assess the impact of intervention measures on the pandemic.

MOLECULAR BIOLOGY AND EVOLUTION (2021)

Add to Collection

Article Microbiology

Repurposing Nucleoside Analogs for Human Coronaviruses

Keivan Zandi et al.

Summary: Novel nucleoside analogs with antiviral activity against CoV-2 and HCoV-OC43 were identified, while sofosbuvir was found to have no antiviral effect against CoV-2.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Add to Collection

Article Cell Biology

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Timothy P. Sheahan et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Add to Collection

Article Infectious Diseases

Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series

Merle M. Boehmer et al.

LANCET INFECTIOUS DISEASES (2020)

Add to Collection

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Bette Korber et al.

CELL (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology

Natacha S. Ogando et al.

JOURNAL OF GENERAL VIROLOGY (2020)

Add to Collection

Article Physiology

Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells

Su-Ling Loo et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)

Add to Collection

Article Virology

Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2

Zhe Liu et al.

JOURNAL OF VIROLOGY (2020)

Add to Collection

Article Virology

Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures

Abigail Vanderheiden et al.

JOURNAL OF VIROLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

Leonid Yurkovetskiy et al.

CELL (2020)

Add to Collection

Article Cell Biology

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice

Andrea J. Pruijssers et al.

CELL REPORTS (2020)

Add to Collection

Article Genetics & Heredity

Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein

Andrew D. Davidson et al.

GENOME MEDICINE (2020)

Add to Collection

Article Virology

Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV

Kumari G. Lokugamage et al.

JOURNAL OF VIROLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19

Xuping Xie et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Multidisciplinary Sciences

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters

Robbert Boudewijns et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Immunology

Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction

Siu-Ying Lau et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection

Article Virology

Determining the Replication Kinetics and Cellular Tropism of Influenza D Virus on Primary Well-Differentiated Human Airway Epithelial Cells

Melle Holwerda et al.

VIRUSES-BASEL (2019)

Add to Collection

Article Pharmacology & Pharmacy

Antiviral drug screening by assessing epithelial functions and innate immune responses in human 3D airway epithelium model

Bernadett Boda et al.

ANTIVIRAL RESEARCH (2018)

Add to Collection

Article Allergy

Propagation of respiratory viruses in human airway epithelia reveals persistent virus-specific signatures

Manel Essaidi-Laziosi et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)

Add to Collection

Article Multidisciplinary Sciences

Link of a ubiquitous human coronavirus to dromedary camels

Victor M. Corman et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Add to Collection

Review Biochemistry & Molecular Biology

Common and unique features of viral RNA-dependent polymerases

Aartjan J. W. te Velthuis

CELLULAR AND MOLECULAR LIFE SCIENCES (2014)

Add to Collection

Article Biochemical Research Methods

A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE

Dirk Jochmans et al.

JOURNAL OF VIROLOGICAL METHODS (2012)

Add to Collection

© Peeref 2019-2024. All rights reserved.